Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients

Antiviral Research

Volumn 103, Issue 1, 2014, Pages 51-59

  Wang, Yadong ^a   Zhao, Caiyan ^a   Zhang, Li ^a   Yu, Weiyan ^a   Shen, Chuan ^a   Wang, Wei ^a   Zhen, Zhen ^a   Zhou, Junying ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Active immune response; Antiviral therapy; Chronic; Hepatitis B; Interferon gamma inducible protein 10 kD (IP 10); Predictive value

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; PEGINTERFERON ALPHA2A; VIRUS DNA;

ACUTE ON CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG DOSE REDUCTION; FEMALE; GRANULOCYTOPENIA; HEPATITIS B; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OPEN STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL CLEARANCE; VIRUS CARRIER; VIRUS LOAD; YOUNG ADULT;

ACTIVE IMMUNE RESPONSE; ANTIVIRAL THERAPY; CHRONIC; HEPATITIS B; INTERFERON-GAMMA INDUCIBLE PROTEIN 10KD (IP-10); PREDICTIVE VALUE;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY; CHEMOKINE CXCL10; DNA, VIRAL; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893119774     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.01.001     Document Type: Article

References (27)

1. S.K. Bae, H. Yatsuhashi, S. Hashimoto, Y. Motoyoshi, E. Ozawa, S. Nagaoka, S. Abiru, A. Komori, K. Migita, M. Nakamura, M. Ito, Y. Miyakawa, and H. Ishibashi Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver Med. Sci. Monit. 18 2012 CR698 CR705
2. A. Casrouge, J. Decalf, M. Ahloulay, C. Lababidi, H. Mansour, A. Vallet-Pichard, V. Mallet, E. Mottez, J. Mapes, A. Fontanet, S. Pol, and M.L. Albert Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV J. Clin. Invest. 121 2011 308 317
3. S.H. Chen, H.L. Wu, J.H. Kao, and L.H. Hwang Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors PLoS One 7 2012 e36984
4. Y.J. Cui, J. Wang, and S.Q. Jiang Expression of IL-8, IP-10 and its mRNA in serum and PBMC of the patients with primary hepatic carcinoma Mod. Prev. Med. 37 2010 1948 1950
5. G. Fattovich, L. Covolo, S. Bibert, G. Askarieh, M. Lagging, S. Clement, G. Malerba, M. Pasino, M. Guido, M. Puoti, G.B. Gaeta, T. Santantonio, G. Raimondo, R. Bruno, P.Y. Bochud, F. Donato, and F. Negro IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C Aliment. Pharmacol. Ther. 33 2011 1162 1172
6. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, F. Gudat, H. Denk, V. Desmet, G. Korb, and R.N. MacSween et al. Histological grading and staging of chronic hepatitis J. Hepatol. 22 1995 696 699
7. J. Jaroszewicz, H. Ho, A. Markova, K. Deterding, K. Wursthorn, S. Schulz, C.T. Bock, H.L. Tillmann, M.P. Manns, H. Wedemeyer, and M. Cornberg Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues Antivir. Ther. 16 2011 915 924
8. R. Jiang, X. Feng, Y. Guo, Q. Lu, J. Hou, K. Luo, and N. Fu T helper cells in patients with chronic hepatitis B virus infection Chin. Med. J. 115 2002 422 424
9. M. Lagging, G. Askarieh, F. Negro, S. Bibert, J. Soderholm, J. Westin, M. Lindh, A. Romero, G. Missale, C. Ferrari, A.U. Neumann, J.M. Pawlotsky, B.L. Haagmans, S. Zeuzem, P.Y. Bochud, K. Hellstrand, and D.-H.S. Group Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms PLoS One 6 2011 e17232
10. J.M. Lee, S.H. Ahn, H.S. Kim, H. Park, H.Y. Chang, Y. Kim do, S.G. Hwang, K.S. Rim, C.Y. Chon, K.H. Han, and J.Y. Park Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir Hepatology 53 2011 1486 1493
11. Y.F. Liaw, N. Leung, J.H. Kao, T. Piratvisuth, E. Gane, K.H. Han, R. Guan, G.K. Lau, and S. Locarnini Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepat. Int. 2 2008 263 283
12. A.S. Lok, M.G. Ghany, G. Watson, and B. Ayola Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B J. Viral Hepat. 5 1998 171 178 (Pubitemid 28374726)
13. Y.W. Luo, J.M. Luo, S.D. Lin, and X.D. Yi Detection and clinical significance of serum interferon-inducible protein-10 and interferon-γ in patients with severe hepatitis B Chin. J. Infect. Dis. 26 2008 244 247
14. S.W. Ma, X. Huang, Y.Y. Li, L.B. Tang, X.F. Sun, X.T. Jiang, Y.X. Zhang, J. Sun, Z.H. Liu, W.G. Abbott, Y.H. Dong, N.V. Naoumov, and J.L. Hou High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B J. Hepatol. 56 2012 775 781
15. S. Moriai, M. Takahara, T. Ogino, T. Nagato, K. Kishibe, H. Ishii, A. Katayama, N. Shimizu, and Y. Harabuchi Production of interferon-{gamma}- inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells Clin. Cancer Res. 15 2009 6771 6779
16. B.A. Payer, T. Reiberger, J. Aberle, P. Ferenci, H. Holzmann, A. Rieger, and M. Peck-Radosavljevic IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients Eur. J. Clin. Invest. 42 2012 599 606
17. T. Reiberger, J.H. Aberle, M. Kundi, N. Kohrgruber, A. Rieger, A. Gangl, H. Holzmann, and M. Peck-Radosavljevic IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection Antivir. Ther. 13 2008 969 976
18. V. Rijckborst, B.E. Hansen, Y. Cakaloglu, P. Ferenci, F. Tabak, M. Akdogan, K. Simon, U.S. Akarca, R. Flisiak, E. Verhey, A.J. Van Vuuren, C.A. Boucher, M.J. ter Borg, and H.L. Janssen Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels Hepatology 52 2010 454 461
19. A.I. Romero, M. Lagging, J. Westin, A.P. Dhillon, L.B. Dustin, J.M. Pawlotsky, A.U. Neumann, C. Ferrari, G. Missale, B.L. Haagmans, S.W. Schalm, S. Zeuzem, F. Negro, E. Verheij-Hart, K. Hellstrand, and D.-H.S. Group Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection J. Infect. Dis. 194 2006 895 903 (Pubitemid 44454074)
20. S.K. Sarin, A. Kumar, J.A. Almeida, Y.K. Chawla, S.T. Fan, H. Garg, H.J. de Silva, S.S. Hamid, R. Jalan, P. Komolmit, G.K. Lau, Q. Liu, K. Madan, R. Mohamed, Q. Ning, S. Rahman, A. Rastogi, S.M. Riordan, P. Sakhuja, D. Samuel, S. Shah, B.C. Sharma, P. Sharma, Y. Takikawa, B.R. Thapa, C.T. Wai, and M.F. Yuen Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) Hepat. Int. 3 2009 269 282
21. M.J. Sonneveld, P. Arends, A. Boonstra, B.E. Hansen, and H.L. Janssen Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B J. Hepatol. 58 2013 898 903
22. J. Wang, P.P. Wang, G.J. Xiang, and X.B. Hu Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis Hepatobiliary Pancreat. Dis. Int. 9 2010 280 286
23. J. Wang, J.H. Zhao, P.P. Wang, and G.J. Xiang Expression of CXC chemokine IP-10 in patients with chronic hepatitis B Hepatobiliary Pancreat. Dis. Int. 7 2008 45 50 (Pubitemid 351247056)
24. WHO, July 2012. Hepatitis B, Fact sheet No. 204.
25. J.F. Wu, T.C. Wu, C.H. Chen, Y.H. Ni, H.L. Chen, H.Y. Hsu, and M.H. Chang Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion Gastroenterology 138 165-172 2010 e161 e163
26. H. Yang, Y.W. Luo, H.Q. Liu, W. Hou, and J. Li CXCR3 and IP 10 expression in patients with chronic hepatitis B and their correlation with degree of liver inflammation and hepatic fibrosis Acta Academiae Medicinae Militaris Tertiae 34 2012 250 253
27. M. Zeremski, R. Dimova, J. Astemborski, D.L. Thomas, and A.H. Talal CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C J. Infect. Dis. 204 2011 832 836